Definitive Contract 75D30119C06841
Award Date 9/19/19
Potential Completion Date 3/31/22
Potential Value $699K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60611, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
95
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention awarded a $536,346 definitive cost no fee contract to Ann & Robert H. Lurie Children's Hospital of Chicago Office of Sponsored Programs Division, doing business as Children's Memorial Hospital, to assess the molecular epidemiology of gas isolates among children. The prime contractor will perform work under Broad Agency Announcement Topic 22.1 to analyze the molecular epidemiology of bacterial isolates from children in order to help the Centers...
- <p>The Centers for Disease Control and Prevention (CDC) awarded a $914,074.43 definitive contract to The Johns Hopkins University under Broad Agency Announcement Topic 22.1 to assess the molecular epidemiology of Group A Streptococcus isolates among children. The prime contractor, The Johns Hopkins University, will perform this work in Baltimore, Maryland over a two-year period from September 2022 through September 2024. The contract utilizes a firm fixed price contract type.</p>
- This is a $9,730,025.00 definitive, firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, which does not have a set-aside designation, is for a scientific study with an ultimate completion date of February 22, 2028. Boston Children's Hospital, an institution affiliated with Harvard Medical School, has...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $488,971.00 definitive cost-no-fee contract to The Children's Hospital of Philadelphia (CHOP) to provide a "Metric for Benchmarking Antibiotic Use". The contract does not have a set-aside designation. CHOP is a pediatric hospital and research center that has received numerous federal contracts and grants from agencies such as the Department of Health and Human Services and the National...
- This is a $31,468,032.25 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract, titled "FLUMED FOR OTHER FUNCTIONS," has a firm fixed-price pricing arrangement and an ultimate completion date of January 30, 2023. The contract does not have a set-aside designation. Through this award, Boston...
- This is a $100,000.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract does not have a set-aside designation. The contract supports data collection on consumer product-related injuries, studies on respiratory viral transmission in K-12 schools, epidemiological research on symptomatic and asymptomatic...
- This firm fixed-price definitive contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Rush University Medical Center, a non-profit academic medical center and hospital located in Chicago, Illinois. The $518,542.00 contract is for "Genomic Epidemiology of MRSA" with a period of performance through April 29, 2020. The contract does not have a set-aside designation. Rush University Medical Center, operating under the...
- The Children's Hospital of Philadelphia has been awarded a definitive cost-no-fee contract valued at approximately $1.28 million by the Centers for Disease Control and Prevention under Fiscal Year 2021 Broad Agency Announcement Topic 8. The contract supports the CDC's mission through the prime contractor's research efforts on behalf of the CDC's Pittsburgh office. Performance will take place in Atlanta, Georgia over a 26-month period concluding in November 2023. No subcontractors or set-aside...
- This is a $24,899,418.92 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The contract is for a COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C) Vaccine Effectiveness (VE) study, with a period of performance ending on September 15, 2026. The contract does not have a set-aside...
- This is a $6,157,849.35 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Children's Mercy Hospital, a non-profit pediatric medical center and research institution located in Kansas City, Missouri. The contract is for a Broad Agency Announcement (BAA) research effort focused on the epidemiology of symptomatic and asymptomatic respiratory viruses, as well as the evaluation of COVID-19 and influenza vaccine effectiveness in K-12 populations. The contract does...